CORC  > 暨南大学
Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate
Liang, Yinji[1]; Lin, Chenli[2]; Zhang, Yupei[3]; Deng, Yuanjun[3]; Liu, Chan[2]; Yang, Qinhe[3]
2018
卷号26期号:4页码:1051
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4465266
专题暨南大学
作者单位1.[1]Jinan Univ, Sch Nursing, 601 Huangpu Rd West, Guangzhou 510632, Guangdong, Peoples R China
2.[2]Jinan Univ, Sch Basic Med, 601 Huangpu Rd West, Guangzhou 510632, Guangdong, Peoples R China
3.[3]Jinan Univ, Sch Tradit Chinese Med, 601 Huangpu Rd West, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Liang, Yinji[1],Lin, Chenli[2],Zhang, Yupei[3],et al. Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate[J],2018,26(4):1051.
APA Liang, Yinji[1],Lin, Chenli[2],Zhang, Yupei[3],Deng, Yuanjun[3],Liu, Chan[2],&Yang, Qinhe[3].(2018).Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate.,26(4),1051.
MLA Liang, Yinji[1],et al."Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate".26.4(2018):1051.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace